REFARMED CHEMICALS presents RamoseTron HCl, a high-purity pharmaceutical agent that serves as a critical component in mitigating the discomforting side effects associated with cancer treatments. Primarily utilized for its antiemetic properties, RamoseTron HCl is an effective serotonin (5-HT3) receptor antagonist, specifically formulated to prevent and treat nausea and vomiting induced by chemotherapy and radiation therapy. This product showcases our commitment to improving patient care during the rigorous journey of cancer treatment. RamoseTron HCl exhibits a remarkable ability to bind and block 5-HT3 receptors both in the gastrointestinal tract and the central nervous system—areas pivotal in cueing nausea and vomiting. By interrupting the signal transmission that triggers these adverse reactions, RamoseTron HCl lessens the severity and frequency of these symptoms, providing patients with much-needed relief. Tailored for adults and adolescents, RamoseTron HCl is administered orally or intravenously, dosed accordingly to align with the intensity of the emetogenic chemotherapy protocols. It ensures a rapid absorption with an extensive distribution throughout the body, assuring efficacy. The product is presented as a white to slightly yellowish-white crystalline powder, notable for its solubility in methanol, water, and ethanol—making it versatile for various pharmaceutical formulations. It meets rigorous quality standards, with certifications such as EU GMP, affirming its adherence to the highest production protocols. While offering substantial aid to cancer patients, healthcare providers must be attentive to possible contraindications and exercise caution in patients with specific medical conditions. Adverse effects, while generally manageable, must also be considered in the comprehensive patient care plan. REFARMED CHEMICALS' RamoseTron HCl is more than a medicine; it is a supportive ally for patients and healthcare providers in the fight against cancer and its challenging treatment side effects. Our product’s detailed specifications, as seen in the provided image, underscore our commitment to transparency and quality assurance.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Refarmed Chemicals takes pride in providing the pharmaceutical industry with high-quality Ticlopidine Hydrochloride, an essential antiplatelet medication used to prevent strokes and other significant blood clots in patients who have experienced a stroke or transient ischemic attack (TIA). Manufactured under stringent GMP certification, our Ticlopidine Hydrochloride is presented in tablet form, with a strength of 250 mg ensuring consistent dosing and efficacy. Our Ticlopidine Hydrochloride acts by hindering platelet function, thereby diminishing the aggregation essential to blood clot formation. This preventive approach serves as a critical intervention in the management of clot-related disorders, significantly improving patient outcomes. Physicians typically recommend a starting dose of 250 mg administered twice daily, emphasizing that food intake during administration reduces gastrointestinal discomfort. Monitoring patient response allows for personalized treatment adjustments to optimize therapeutic benefits while considering safety profiles. As with all pharmaceuticals, we duly note possible side effects, ranging from mild gastrointestinal issues to less common, yet more severe reactions like neutropenia or liver impairment. This necessitates caution in prescribing to populations with liver disease, a history of bleeding disorders, or inflammatory bowel disease. Continuous patient monitoring and drug interaction vigilance are paramount, especially concerning commonly used medications such as aspirin and warfarin. Compliant storage conditions entail keeping the Ticlopidine Hydrochloride tablets at room temperature (15°C to 30°C), shielded from light and moisture to maintain product integrity. Ticlopidine Hydrochloride is supplied as a generic medication, ensuring affordability without compromising quality. Embracing our commitment to patient safety and treatment adherence, we underline the significance of medical guidance before initiating or discontinuing use, with particular respect to special populations like pregnant or breastfeeding women. Rest assured, our partnership with the DKSH Group underlines a shared vision for growth and delivery of quality healthcare solutions that spans across Asia and beyond, cementing our position as a trusted supplier in the pharmaceutical landscape.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Bilastine is a white to off-white crystalline powder that is sparingly soluble in methylene chloride and practically insoluble in acetone. It has an assay range of 98.0% to 102.0%.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Refarmed Chemicals presents Ciprofibrate, a crucial pharmaceutical material developed for clinical efficacy in managing lipid disorders. Developed with the utmost precision, Ciprofibrate is a fibrate-class drug specially formulated as a therapeutic agent to regulate high levels of cholesterol and triglycerides, factors leading to cardiovascular diseases. Our product is synthesized with rigorous compliance to quality standards, evidenced by its Good Manufacturing Practice (GMP) certification. The drug appears as a white or slightly yellow-white crystalline powder, indicative of its purity. Highly soluble in anhydrous ethanol and toluene yet practically insoluble in water, Ciprofibrate facilitates flexibility in pharmaceutical formulation, allowing for both tablet and capsule dosage forms in strengths of 100mg and 200mg. Targeting primary hypercholesterolemia (type IIa or IIb), mixed dyslipidemia, and as preventive treatment against cardiovascular events in high cholesterol patients, Ciprofibrate's composition facilitates the acceleration of cholesterol and triglyceride breakdown and removal from the body. Recommended for bi-daily intake alongside meals, the treatment's efficacy is augmented by adherence to healthy lifestyle choices, including a balanced diet and regular exercise. Safety parameters dictate careful administration especially to those with a history of gallbladder disease, and periodic liver function evaluations are advised. Contraindications include severe renal or hepatic conditions, pregnancy, breastfeeding, or known hypersensitivity to fibrates. Consultation with healthcare professionals is critical when concomitant medications are involved, particularly statins, anticoagulants, and antibiotics. Storage requirements for Ciprofibrate are straightforward — room temperature conditions away from light and moisture ensure stability. As a product from the storied catalogue of Refarmed Chemicals, now part of the DKSH Group, Ciprofibrate is accompanied by dependable documentation for Detailed and Master Files, affirming its reputable standard in pharmaceutical resources.

Products still subject to third-party patent protection might be available solely for R&D purposes.